User profiles for Ramesh Nachimuthu
Dr. Ramesh Nachimuthu (Phage Man)Medical and Health Sciences / Medical Microbiology Verified email at vit.ac.in Cited by 2480 |
[HTML][HTML] Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species
…, AJ Tamhankar, CS Lundborg, R Nachimuthu - Frontiers in …, 2019 - frontiersin.org
Infections due to antibiotic resistant bacteria are increasing globally and this needs immediate
attention. Bacteriophages are considered an effective alternative for the treatment of …
attention. Bacteriophages are considered an effective alternative for the treatment of …
[HTML][HTML] Isolation, characterization and in vivo efficacy of Escherichia phage myPSH1131
Phage therapy is the use of lytic bacteriophages to cure infections caused by bacteria. The
aim of this study is to isolate and to characterize the bacteriophages against Escherichia coli …
aim of this study is to isolate and to characterize the bacteriophages against Escherichia coli …
Synergistic Effects of Phage–Antibiotic Combinations against Citrobacter amalonaticus
Non-antibiotic alternative treatments to combat the increasing number of infections caused
by multidrug resistant bacteria are urgently needed. In recent years, bacteriophages have …
by multidrug resistant bacteria are urgently needed. In recent years, bacteriophages have …
[HTML][HTML] Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics?
Secondary bacterial infections manifest during or after a viral infection(s) and can lead to
negative outcomes and sometimes fatal clinical complications. Research and development of …
negative outcomes and sometimes fatal clinical complications. Research and development of …
[HTML][HTML] Secondary bacterial infections in patients with viral pneumonia
Pulmonary diseases of viral origin are often followed by the manifestation of secondary
infections, leading to further clinical complications and negative disease outcomes. Thus, …
infections, leading to further clinical complications and negative disease outcomes. Thus, …
The distribution of carbapenem-and colistin-resistance in Gram-negative bacteria from the Tamil Nadu region in India
…, AJ Tamhankar, R Nachimuthu… - Journal of medical …, 2017 - microbiologyresearch.org
Purpose. The occurrence of carbapenem- and colistin-resistance among Gram-negative
bacteria is increasing worldwide. The aim of this study was to understand the distribution of …
bacteria is increasing worldwide. The aim of this study was to understand the distribution of …
[HTML][HTML] Improved lyophilization conditions for long-term storage of bacteriophages
Phage therapy is one of the promising alternatives to combat the increasing problem of
antibiotic resistance. Lyophilization is used for the preparation of pharmaceutical products to …
antibiotic resistance. Lyophilization is used for the preparation of pharmaceutical products to …
[HTML][HTML] The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model
Background Phage therapy is the therapeutic use of bacteriophages to treat highly drug
resistant bacterial infections. The current surge in bacteriophage therapy is motivated mainly …
resistant bacterial infections. The current surge in bacteriophage therapy is motivated mainly …
[HTML][HTML] Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer—A protocol for systematic review and meta-analysis
…, K Lakhotiya, S Samiappan, S Baxi, R Nachimuthu… - Medicine, 2019 - journals.lww.com
Background: The neutrophil-lymphocyte-ratio, platelet-lymphocyte-ratio, and monocyte-lymphocyte-ratio
have been explored as a simple, inexpensive, and effective method for cancer …
have been explored as a simple, inexpensive, and effective method for cancer …
[HTML][HTML] The role of antimicrobial peptides as antimicrobial and antibiofilm agents in tackling the silent pandemic of antimicrobial resistance
Just over a million people died globally in 2019 due to antibiotic resistance caused by
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, …
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, …